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INTRODUCTION 
Aging is associated with functional decline in several components of the immune 
system. As a result of this age-associated decrement of the immune system, the elderly 
appeaz to be at an increased risk of contracting infectious diseases and also experience a 
greater incidence of autoimmune disorders. Upon infection, older adults often have higher 
mortality rates than the young. These changes in the immune responsiveness may 
compromise health status of older adults. 
The functions of many immune cell types change with age, but the T-cell is most 
affected by the aging process. The T-cells show a decreased ability to proliferate when 
stimulated by mitogens. Within the T-cell subsets, both CD4+ and CD8+ cell numbers 
decrease with age, but the effect is more pronounced with respect to CDB+ T-cells, resulting 
in an age-related increase in the CD4:CD8 ratio. The production of an important cytokine, 
IL-2, also decreases with age. The activity of cytotoxic T-lymphocytes also declines with 
age. The consequence of these changes may be a reduced ability to respond to new antigens 
and cleaz infectious agents. 
Changes in the aging immune system represent a permissive factor for the frequent 
occurrence and the severity of disease. Vaccine efficacy is also impaired in elderly 
populations. Efficient protection of elderly individuals through vaccination strategies is a 
matter of great importance. Therefore, any intervention that can improve the immune 
response to immunization may reduce the incidence of infection. 
Interventions such as diet and/or exercise may influence immunity. Moderate 
exercise has been associated with enhanced immune responses to nonspecific immune 
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activators. Also, vitamin E has been targeted as enhancing the immune function in aged 
animals and elderly people.. 
The parameters that we researched within this study include antibody titer, 
lymphocyte proliferation, and cytokine production (interleukin-2, interleukin-10, and 
interferon gamma). Antibodies, secreted by B-cells, are proteins that specifically bind a wide 
variety of protein antigens. They are produced in response to either an infectious agent or 
vaccination. They elicit a response that is significant in antimicrobial defense. Antibodies 
are the mediators of circulating immunity and their presence on mucosal surfaces provides 
resistance to many infectious agents (1). 
Lymphocytes are one of the main types of immune cells. The two main types of 
lymphocytes are the B and T cells. B cells are important for secreting antibodies. T cells 
work primarily by secreting cytokines. They direct and regulate the immune responses. 
Other T cells act as killer cells by attacking cells that are infected (1). 
Cytokines are protein hormones produced during the activation and effector phases of 
innate and specific immunity. They serve to mediate and regulate immune and inflammatory 
responses. Cytokines are a means of intracellular communication. They are generally 
secreted by one cell to stimulate the activity of another cell (1). 
Our study examined exercise as an intervention to improve the immune response to 
influenza vaccine. The effects of a long-term exercise intervention on immune response are 
essentially unknown. In this study, we will also look as the diet and the role that it may play 
in the immune response. 
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LITERATI:~ZE RE VIE W 
BASIC IMMUNE RESPONSE 
The immune system is a network of cells and organs that work together to defend the 
body against attacks by foreign invaders. The immune system is amazingly complex. It can 
recognize millions of different enemies and produce secretions and cells to match up with 
and destroy each one of them. The immune system is involved in a communication network 
in which cells pass information back and forth among one another. Once the immune cells 
receive an alarm from an invader, they undergo changes and produce powerful chemicals. 
Anything that can trigger an immune response it called an antigen. An antigen can be 
a germ such as a virus, or even part of a virus. Antigens carry marker molecules that identify 
themselves as foreign to the immune cells. An immune response can also be sparked by 
immunization with vaccines. Vaccines contain microorganisms, or parts of organisms, that 
have been treated so they will be able to provoke an immune response, but not a mature 
isease. 
INFLUENZA IMMUNIZATION AND ANTIBODY TITER 
Influenza is a significant cause of morbidity and mortality in the elderly populations. 
Estimates are that more than 80% of deaths from influenza occur in adults > age 65 (2). 
Following immunization, protection against infection is also reduced in the elderly. For 
example, among the persons over age b5 hospitalized for influenza, 58-61 %had been 
previously vaccinated (3,4). Vaccine efficacy estimated for the elderly ranges from 31 % to 
65% in preventing influenza (5). This is quite low, especially when compared to the vaccine 
efficacy seen in younger adults, which ranges from 70% to 90% (4). 
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Many vaccinated elderly demonstrate a decreased antibody response against influenza 
immunization which may account for the decreased vaccine efficacy. Serum antibody, 
mainly IgG, produced after vaccination, has the capability of neutralizing viral particles and 
thus protects against infection. Hemagglutination inhibition (HI) antibody titers > 40 are 
considered protective in young people (6). The antibody titer is the primary predictor for an
immune response, having the greatest correlation with protection. from influenza. Several 
studies have shown that at least 25% of the elderly do not develop HI antibody titers > 40 in 
response to vaccine (4,7,8). 
Not all studies suggest an age-related decrease in humoral immune responsiveness to 
vaccination. However, in the elderly, antibody responses that are equal in magnitude to 
young people may not provide the same level of protection from influenza. There may be a 
large percentage of elderly with influenza infections who have post-vaccination titers > 40 
and still suffer from influenza infection. For example, in one study Gravenstein and 
colleagues showed that of 72 vaccinated elderly who were later confirmed to have 
influenza infection, 60% had titers > 40 and 31 %had titers > 640 four weeks after 
vaccination (9). This suggests that levels of antibody considered protective in the young are 
not necessarily protective in the elderly. 
To determine the influence of aging a.s well as the priming histories on the antibody 
response to influenza vaccination, 43 healthy young subjects and 5 5 elderly subjects were 
compared. Remarque and others found that elderly were capable in mounting similar 
antibody responses to the influenza vaccine strains as healthy young subjects. For certain 
strains, antibody responses were lower in the elderly compared to young subjects. He 
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concluded that the strain-related difference in the antibody response may be due to a 
difference in priming histories, rather than a result of the aging immune system (12). 
ELDERY AND INFLUENZA VACCINATION 
The reduced capacity of elderly people to mount an effective immune response 
has been well documented (11). Influenza vaccines are only effective in 30% to 50% of the 
elderly population immunized (12), leaving the elderly population at a large risk for life-
threatening illness. More than 80% of influenza-related deaths occur in people 6~ years and 
older (13 ). 
Strasburg and colleagues researched on influenza outbreaks in nursing homes during 
1967 to 1982 and the effectiveness of the influenza vaccination. Compared with 
unvaccinated residents, the mean reduction of mortality in vaccinated residents was 67% 
(14). However, the reduction of morbidity was much lower (23%). 
It is known that older people have a lower antibody titer response to influenza 
vaccination than younger people, but other factors, such as cellular immunity may influence 
resistance to influenza. 
INFLUENZA AND CELL-MEDIATED IMMUNITY 
In regards to cell-mediated immunity, age associated decrements of immune function, 
particularly T-lymphocyte function, likely contribute to the increased incidence and severity 
of influenza infection. Upon infection, cell-mediated responses, particularly cytotoxic T-
lymphocytes, are significant in viral clearance (1 S). It is suggested that cell mediated 
immune responses to influenza vaccination are also impaired in the elderly, mostly related to 
a decline in T-cell function. Cytokines produced by T-cells drive cytotoxic effector function 
and antibody production, and therefore may be of great importance in terms of disease 
6 
outcome and the development of immune protection following vaccination. Young people 
produce greater amounts of the influenza specific interleukin-2 (IL-2) and interferon - y 
(IFN-y) post-vaccination than older adults (4), so it is possible that the age-associated 
decrease in cell-mediated immune effector function is related to decreased IL-2 and/or II~N-y. 
Cell-mediated immune responses, particularly T-helper cells, are important in 
promoting antibody production by producing cytokines. Naive and memory helper T-cells 
have different activation requirements in vitro, and differ in their lymphokine profiles. Thus, 
the altered composition of the helper T cell compartment may result in qualitative and 
quantitative differences in T-cell help delivered to B cells, which in turn can influences the 
antibody levels. Remarque and colleagues found that the number of helper T cells with 
memory phenotype are positively correlated with the IgG response to the influenza 
vaccination. However, age-related differences in the composition of the helper T cell 
compartment, such as a decline in naive helper T-cells and increase in memory helper T-
cells, did not explain age-related differences in antibody production (16). 
STRATEGIES TO ENHANCE VACCINE EFFICACY 
The post-vaccination antibody levels achieved are not as high in the old a.s in the 
younger populations. An approach to increasing the rate of vaccine protection has been the 
development of the cold adapted live attenuated vaccine by Maassab and colleagues (10). In 
this study, the use of the cold adapted live attenuated vaccine did not reduce infection rates, 
and antibody titers remained lower among the elderly (17). Cold adapted vaccine almost 
completely blocked infection and clinical illnesses among the young. It appears that cold 
adapted vaccines are more efTicacious among the young, healthy subjects, but less effective 
among the elderly population. 
A novel oil-in-water emulsion, MF59, has been tested on elderly people as a method 
of improving vaccine efficacy. MF59 has been known to stimulate immune response. When 
combined with the influenza vaccine, fewer deaths occurred among the recipients who 
received MF59. The MF59 emulsion was thought to stimulate immune functions that 
typically decrease with age (18). 
Dehydroepiandrosterone (DHEA) treatment has also been tried as a method of 
improving influenza vaccine effectiveness in the elderly. Numerous animal studies have 
demonstrated beneficial effects of DHEA administration in preventing atherosclerosis, 
cancer, and immunosenescence. However, human studies with DHEA did not find a 
beneficial effect on antibody titer post-immunization (3). 
EXERCISE AND IMMUNITY 
It is possible that exercise may enhance immunity in the elderly population. There is 
growing belief that endurance exercise may slow the age-related decline in immune function 
(19). A few cross-sectional comparisons of immune status between physically fit elderly 
individuals and sedentary controls suggest that regular physical activity may enhance natural 
killer (NK) cell activity (20, 21, 22). Highly trained elderly individuals have enhanced 
lymphocyte proliferation and cytokine production in response to mitogen stimulation 
compared to sedentary elderly people (23,24), suggesting that exercise may also enhance T- 
cell function. Some recent results have demonstrated that anti-influenza antibody titer (IgG 
and IgM) were greater in active participants as compared to moderately active or sedentary 
participants (25). A couple of studies utilizing 12 weeks of exercise as an intervention failed 
to find an enhancement of mitogen-induced T-cell function or NK cell cytotoxicity (23,26). 
This may be because an exercise intervention of longer duration is necessary to elicit 
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significant changes in immune response in elderly. Six months of exercise in a separate 
controlled trial showed a trend towards increased mitogen-induced T-cell proliferation and 
increased NK activity (27). Perhaps an exercise intervention of a longer duration (> 6 
months) may be necessary to elicit statistically significant changes in immune function. 
DIET AND IMMUNITY 
Dietary intakes can affect the function of immune system. The impact of diet and 
specific food groups on aging has been widely recognized in recent yeazs. The free radical 
theory of aging suggest that there is a shift in the antioxidantlpro-oxidant balance that leads 
to increased oxidative stress and dysregulation of cellular function. Several epidemiological 
and clinical studies have revealed potential roles for dietary antioxidants in the age- 
associated decline of immune function. It has been reported that long term vitamin E 
supplementation enhances immune function in aged animals and elderly subjects (28). 
Evidence suggests that a level of vitamin E greater than the currently recommended level 
enhances certain clinically relevant in vivo indexes of T-cell-mediated function in the elderly 
population (29,30). Meydani and others found asix-fold increase in antibody titer to 
hepatitis and a significant increase in antibody titer to tetanus vaccine in elderly individuals 
who were supplemented with 200 mg/d of vitamin E compared to the placebo group (29). 
Han and colleagues compared the erect of vitamin E on the course of influenza infections 
with that of other antioxidants in mice. From this mouse study, they concluded that only 
vitamin E supplementation was effective in reducing pulmonary viral titers and preventing an
influenza-mediated decrease in food intake and weight loss (31). 
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STATEMENT OF THE PROBLEM 
An age-related decline in several components of the immune system puts the elderly 
population at a great risk for developing infections and diseases. The purpose of this study is 
to determine whether moderate to vigorous aerobic exercise training can enhance influenza-
specific immune response among the elderly population. A second 
purpose is to determine if nutrient intake is associated with the immune response to influenza 
immunization. The hypothesis is that 10 months of supervised moderate to vigorous aerobic 
exercise will enhance influenza-specific immune response following immunization in 
individuals > 65 years of age. A second hypothesis is that there will be an same association 
between nutrients and the immune response to the influenza vaccination in individuals > 65 
years of age. 
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EXPERIMENTAL DESIGN AND METHODOLOGY 
In this study, the hypothesis tested was that 10 months of moderate to vigorous 
aerobic exercise will increase the influenza-specific immune responses following 
immunization in individuals > 65 years of age. The immune outcome measures included aze: 
influenza-specific lymphocyte proliferation, influenza-specific cytokine production (IL-2, 
IFNy, IL-10 measured in supernatants by ELISA), and anti-influenza antibody titer. 
Fourteen sedentary subjects (7 male, 7 female) were assigned to a 10-month aerobic exercise 
intervention. Preliminary studies have detected differences in the immune response to 
influenza immunization based on reported activity level within an average of 14 per group. 
Thirteen people (6 male, 7 female) served as control subjects. Originally there were fourteen 
controls, but a quarter of the way through the study one subject developed cancer and was 
required to terminate from the study. The control group members were instructed to continue 
with current activity levels. The control group either had not exercised on a regular basis 
and/or scored in the lowest quartile for aerobic fitness measured by asix-minute walk test. 
Each of the subjects signed an informed consent that was approved by the ISU Human 
Subjects in Research Committee. 
SUBJECTS 
Fourteen subjects, 7 male and 7 female, age > 65, not currently participating in any type of 
consistent aerobic exercise were recruited from the local community to participate in he 
proposed research study. Thirteen subjects, 6 male and 7 female, aged > 65, considered 
sedentary and/or low aerobic fitness were selected to serve as controls. Subjects were 
defined as healthy, but may not have met the rigid selection set forth in the SE1~tIEUR 
protocol. Subject inclusion and exclusion was dependent on age, health 
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status, exercise history, medication use, influenza vaccination history, and ability to perform 
aerobic exercise on a regular basis. Reasoning for the lower age limit of 65 was based upon 
research suggesting that immune response to vaccination maybe impaired as age increases. 
There was no set upper limit selected with regards to age. However, the upper age limit was 
affected by the ability of the subjects to perform the aerobic exercise intervention. Health 
status was determined by a detailed medical history. Exclusion from the study included any 
individuals suffering from any condition that may have altered the immune variables of 
interest (i.e., autoimmune disorder, malignancy, etc.). Also, any subject experiencing a 
disease or condition that may have impaired the ability to safely perform the exercise 
intervention was excluded from the study. Subjects assigned to the exercise group completed 
a maximal graded exercise test. The maximal graded exercise test screened potential subjects 
for the ability to perform the exercise intervention. An abnormal maximal exercise test 
resulted in exclusion from the study. However, none of the subjects were excluded for this 
reason. Medication use also limited participation in the study. Subjects treated with 
medications known to alter immune response were excluded from the study. Prior exercise 
history was another criterion for inclusion into the study. Subjects were included in the study 
if in the past two years they did not exercise or if they engaged in aerobic exercise < 40% of 
the heart rate reserve < 3 times per week, or if their aerobic fitness was in the lowest quartile 
for that age and gender. If the exercise heart rate information was not available, subjects that 
regularly walk at a pace < 2.0 miles per hour or did not report vigorous activity (defined a.s 
strenuous enough to cause large increases in breathing, heart rate, leg fatigue, or produce 
perspiration) were included in the study. Prior vaccination history allowed us to select 
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individuals with a similar antigenic history and therefore, subjects were included in the study 
if they received a flu vaccine in the previous five years. 
TIME-LINE 
The study began within two months prior to the first influenza season. Initial 
recruitment and testing of subj ects was performed during this 2-month period. During the 
fall of 2000, a baseline blood sample (pre-immunization), a fitness assessment adapted for 
older adults, and a diet questionnaire were administered one month prior to immunization as 
part of the initial screening. Aphysician-supervised maximal treadmill test was performed 
on the subjects in the exercise group prior to the exercise intervention. All subjects received 
the 2000/2001 influenza vaccine (A/New Caledonia/20/99, A/Panama/2007/99, 
B/Yamanashi/166/98) in the fall of 2000. Venous blood was collected at 1, 4, and 12-weeks 
post-immunization. After 10 months of participation in either the aerobic exercise or control 
group, the same procedures were followed in terms of measurements taken. In the fall of 
2002, subjects completed a fitness assessment, diet questionnaire, and apre-immunization 
blood-sample was taken. Subjects were vaccinated with the 2001 /2002 influenza vaccine 
(AJNew Caledonia/20/99, A/Panama/2007/99, B/Victorial504/2000). Blood was collected at 
1, 4, and 12-weeks post-immunization for immune analyses. Subjects continued 
participation in either the exercise group or the control group until the final blood sample was 
taken. The following immune variables were assessed by the blood samples: influenza-
specific lymphocyte proliferation, influenza-specific IL-2, IL-10, IFN-y, and anti-influenza 
antibody titer. The selection of immune measures to be assessed at these time points was 
based on data collected in our laboratory and other investigators. We followed the schedule 
below (Table 1). 
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Table 1. Schedule for blood draw immune analysis, fitness tests, and diet 
questionnaires. 
Immunization 
#1 
W 
Immunization 
#2 
W 
Blood 
Draw 
Time in 
Weeks 
Pre- 
Immuni- 
zation #1 
-4 to -1 
Week 1 
Post- 
vaccine 
1 
Week 4 
Post- 
vaccine 
4 
Week 12 
Post- 
vaccine 
12 
Pre- 
immuni- 
nation #2 
40 
Week 1 
Post- 
vaccine2 
42 
Week 4 
Post- 
vaccine2 
45 
Week 12 
Post-
vaccine2 
53 
Antibody 
Titer X X X X X X X X 
Cytokines X X X X X X X X 
Prolif-
Eration X X X X ~ X X X X 
Fitness 
Test X X 
Diet 
Questions _ X X 
ASSESSMENT OF DIET AND FITNESS 
As part of the initial screening, all participants completed a dietary questionnaire 
(block 98 Dietary data systems, Berkeley, CA). Participants were asked to inform the 
investigators regarding any changes in diet or dietary supplement use. 
Fitness tests appropriate for older adults were administered following the 
recommendations given at the recent ACSM Specialty Conference on Physical Activity 
Programming for the Older Adult (32). Physician's approval prior to fitness testing was 
required if the subject had ever had congestive heart failure, was told by a physician not to 
exercise, had pain in chest or joints that maybe made worse by exercise, or had blood 
pressure > 160/90. The fitness tests included a 30 second chair stand, 30 second arm curl, 6 
minute walk, 2 minute step in place, chair sit and reach, back scratch flexibility, 8 foot up 
and go. Height and weight were measured and body composition was assessed using 
14 
skinfold thickness and age-appropriate equations. Fitness tests were done to see if exercise 
program improved all aspect of fitness. However, our hypothesis is based only on improving 
aerobic fitness. 
ASSESSMENT OF INFLUENZA INFECTION 
A11 subjects were called bi-weekly during the influenza season (November-April) to 
answer questions regarding symptoms of illness. If necessary, subjects with symptoms of 
influenza at any time were referred to a physician for laboratory confirmation of influenza 
and appropriate antiviral treatment. This was not necessary in our study. 
BLOOD COLLECTION AND IMMUNIZATION 
All subjects received influenza immunization and blood samples (40 ml) were 
collected between 7-9 a.m. on all blood collection days. Collecting in the morning helped to 
control for the potential influence of daily levels of plasma hormones such a.s cortisol. All 
subjects received influenza immunizations by a registered nurse. Blood 
samples were collected 1-week pre-immunization and 1, 4, and 12-weeks post-immunization 
as described previously under the timeline. 
EXERCISE OR CONTROL INTERVENTION 
After initial measures were taken and the first immunization had been administered, 
exercise participants participated in a supervised aerobic exercise class three times per week. 
They used treadmills, stair-steppers, rowing machines, and cycle ergometers for the twelve-
month intervention period. This period of time had been chosen based on cross-sectional 
comparisons as well as experimental studies suggesting that a longer period of time maybe 
necessary to evoke alteration of the immune function. This is opposed to typical 
improvements in cardiorespiratory fitness that is observed after 8-12 weeks of exercise. 
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Initially, subjects exercised at an intensity corresponding to 40-60% of heart rate reserve 
(HRR) for 20 minutes/session and gradually progressed to an intensity corresponding to 65- 
75% of HRR for 25-30 minutes. The subject's heart rate was monitored by exercise leaders 
or individuals recorded the heart rate from the electronic device on the machine. 
IMMUNE ANALYSES 
Each time blood samples were taken, serum was used for anti-influenza antibody 
analysis and the cell fraction were used for the other immune assays. Peripheral blood 
mononuclear cells (PBMC) were isolated from heparinized blood samples by centrifugation 
over Ficoll-Pague Plus gradient. Cells were washed, adjusted to an appropriate 
concentration, 5 x 10 5 to 2 x 10 ~ cells/ml in AIM-V media. Live influenza virus was added 
to culture (50 HA per ml) to stimulate PBMC proliferation and cytokine production. 
ASSAY FOR CYTOHINE PRODUCTION 
Lymphocyte influenza-specific cytokine production including inerleukin-2 (IL-2), 
interferon-gamma (IFNy), and interleukin-10 (IL-10) was measured in cell supernatants 
using ELISA (enzyme-linked immunosorbent assay). Peripheral blood mononuclear cells 
(PBMC) were cultured with virus. Ninety-six well enhanced protein binding ELISA plates 
were coated overnight with purified IL-2, IFN-y or IL-10 capture mAb. Plates were then 
blocked with PBS-10% fetal bovine serum (FBS). Supernatant samples and standards were 
added to the plates. Biotinylated anti-cytokine detecting mAb were added as well as avidin- 
peroxidase in PBS-10% FBS. The substrate tetramethylbenzidine (TMB) was added and 
absorbance at 405 nm was read with the Bio-Rad Benchmark microplate reader. 
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HEMAGGLUTINATION INHIBITION (HI) ASSAY 
Influenza-specific antibody production in serum was determined by the HI assay. 
Serum was treated with receptor destroying enzyme for 12-18 hours. The following day, 2.5 
of sodium citrate solution was added to serum to inactivate it. Treated samples 
were transferred to 96 well plates, PBS and 50% red blood cells (BBC's) were added also. 
Rooster blood cells were used for H 1 N 1 and B virus, and turkey blood cells were used for 
H3N2 virus. The plate incubated for 30 minutes, then centrifuged for 10 minutes. To 
determine the virus working solution, we performed an HA titration. The last well 
containing an agglutinated mat was considered the end point of the virus titration. The 
working solution was calculated by 8 HA units. Aback titration was performed to be certain 
that the working solution was adjusted correctly. PBS was added to new 96-well plates. The 
serum was added and then a serial 2-fold dilution was made down the plate. Working virus 
was added, incubated for 60 minutes, then .5%BBC's were added. Incubation for 45 
minutes and then the well with the last button was considered the endpoint. 
PROLIFERATION ASSAY 
Influenza-specific lymphocyte proliferation was assessed with an MTT proliferation 
assay. With this colorimetric assay, PBMC were plated with or without influenza for 96 
hours at 37 ° in 5% CO2. MTT (Sigma Chemical Co.) was added for the last 4 hours of 
incubation, followed by the addition of 0.04 N HCl in isopropanol. Absorbance was read at 
dual wavelength of 570 and 630 nm with an automated microplate reader. The absorbance in 
wells without virus was subtracted as background from the absorbance in wells with virus. 
17 
STATISTICS 
A General Linear Model (GL1Vn Multivariate Analysis procedure (SPSS) was used to 
examine whether the factors of gender, exercise treatment, and time alter the immune 
response. 
The potential association between nutrient intake and immunity were assessed with a 
test for correlation. 
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RESULTS 
GENDER EFFECTS 
There was no effect of gender on any of the immune parameters measured. 
Therefore, for all analysis, the data from males and females were combined. 
WEIGHT AND BODY MASS INDEX 
Table 1 summarizes the body weight and body mass index (BMI) of all subjects 
(control=13, exercise =14). Included are both the pre (2000) and post (2001) time points. 
The groups did not differ significantly in either weight or body mass index. 
Table 1. Body mass index (BMI) and weight of groups at pre and post time periods. 
Factor Exercise group Control group 
Pre-BMI 28.5 27.5 
Post-BMI 27.8 27.4 
Pre-weight (pounds) 187 167.3 
Post-weight (pounds) 181.7 168.3 
S~'MPTOM INCIDENCE 
All participants were called bi-weekly concerning influenza signs and symptoms. 
Throughout the study, there was one individual within the control group who demonstrated 
symptoms of influenza one week. 
AEROBIC FITNESS 
After the ten-month exercise intervention, subjects in the exercise group improved 
their six-minute walk distance by 88 meters compared to only a 10-meter increase within the 
control group (Figure 1). This demonstrates that the exercise group's endurance program was 
successful at improving cardiovascular fitness. There was a significant difference at the 2001 
time point between the two groups (p = .016). 
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INTERLEUKIN-2 PRODUCTION 
T'he results from ANOVA suggest that physical activity did not influence IL-2 
production for any of the influenza antigens (Type A H 1 N 1, Type A H3N2, Type B). There 
was not a main effect of treatment or time and there was not a significant treatment by time 
interaction (Figures 2, 3, and 4). 
INTERFERON GAMMA PRODUCTION 
The results from ANOVA suggest that physical activity did not influence IFN y 
production for any of the influenza antigens (Type A H1N1, Type A H3N2, Type B). There 
was not a main effect of treatment of time and there was not a significant treatment by time 
interaction (Figures 5, 6, and 7). 
INTERLEUKIN-10 PRODUCTION 
The results of the ANOVA suggest that physical activity did not influence IL-10 
production for any of the influenza antigens (Type A H1N1, Type A H3N2, Type B). There 
was not a main effect of treatment of time and there was not a significant treatment by time 
interaction (Figures 8, 9, and 10). 
LYMPHOCYTE PROLIFERATION 
Lymphocyte proliferation was not influenced by physical activity for any of the 
influenza antigens (Type A H1N1, Type A H3N2, Type B). There was not a main effect of 
treatment of time and there was not a significant treatment by time interaction (Figures 11, 
12, and 13). 
ANTI-INFLUENZA ANTIBODY TITER 
The exercise group had a significantly greater change in antibody titer from pre- 
immunization to 4-week post immunization for Type A H1N1 (p=.05) and Type A H3N2 
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(p=.038) compared to the control groups (Figures 14, 15, and 16). The change in antibody 
titer from pre-immunization to 4-week post immunization in Type B was not significant 
(p=.311). The change in antibody titer from pre-immunization to 3-month post 
immunization was significant for Type A H 1 N 1 (p=.04). The change in antibody titer from 
pre-immunization to 3-month post immunization was not significant for Type A H3N2 
(p=.382) and Type B (p=.632). In Figure 14, it is shown that the control group's antibody 
titer actually decreased below baseline at the 3-month time point, whereas the exercise group 
increased significantly. 
Table 2 shows the percentages of subjects with antibody titers greater than 1:40 for 
each antigen at two different time-points (4-week post, 3-month post). An antibody titer 
greater than 1:40 is considered at the protective level. 
NUTRIENT INTAKE 
There were no significant differences of nutrient intake among the control and 
exercise group for any of the nutrients measured (Table 3). There was a negative correlation 
between carbohydrate intake and IL-2 production (R2 =.324). There was a trend toward 
increased IL-2 production within subjects who constuned a vitamin C supplement (R2 =.331 ) 
and vitamin E supplement (R2=36) for some of the time points. 
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Figure 1. Difference in mean 6-minute walk times between the control and exercise group 
from 2000 (1) and 2002 (2). The 6-minute walk was measured in meters. The 6-minute 
walk test is a measure of aerobic fitness. 
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Figure 2. Effect of exercise on Interleukin-2 production at four time points in regards to 
influenza antigen Type A H 1 N 1 
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Figure 3. Effect of exercise on Interleukin-2 production at four times in regards to influenza 
antigen Type A-H3N2 
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Figure 4. Effect of exercise on Interleukin-2 production at four time points in regards to 
influenza antigen Type B 
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Figure 5. Effect of exercise on Interferon gamma production at four time points in regards to 
influenza antigen Type A H 1N 1 
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Figure 6. Effect of exercise on Interferon gamma production at four time points in regards to 
influenza antigen Type A H3N2 
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Figure 7. Effect of exercise on Interferon gamma production at four time points in regards to 
influenza antigen Type B 
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Figure 8. Effect of exercise on Interleukin 10 production at four time points in regards to 
influenza antigen Type A H 1 N 1 
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Figure 9. Effect of exercise on Interleukin 10 production at four time points in regards to 
influenza antigen Type A H3N2 
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Figure 10. Effect of exercise on Interleukin 10 production at four time points in regards to 
influenza antigen Type B 
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Figure 11. Effect of exercise on lymphocyte proliferation at four time points in regards to 
influenza antigen Type A H 1N 1 
32 
0.20 
Ab
so
rb
an
ce
 (
56
0/
63
0 n
m
)
 
0.15 - 
0.10 - 
0.05 
0.00 
-0.05 
• Control 
O Exercise 
Pre-immune 1 wk post 4 wk post 3 mth post 
Figure 12. Effect of exercise on lymphocyte proliferation at four time points in regards to 
influenza antigen Type A H3N2 
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Figure 13. Effect of exercise on lymphocyte proliferation at four time points in regards to 
influenza antigen Type B 
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Figure 14. The change in antibody titer (Type A H1Nl) from pre-immunization values are 
shown at 4 weeks post-immunization and 3 months post-immunization. Antibody titer was 
greater in exercise compared to control subjects at both time points (* p<0.05). 
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Figure 15. The change in antibody titer (Type A H3N2) from pre-immunization values are 
shown at 4 weeks post-immunization and 3 months post immunization. Antibody titer was 
greater in exercise compared to control subjects at both time points (* p<0.05). 
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Figure 16. The change in antibody titer (Type B) from pre-immunization values are 
shown at 4 weeks post-immunization and 3 months post-immunization. Antibody 
titer showed a trend toward greater levels in exercise compared to control group at 
both time points. 
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Fable 2. Percentages of each group at the 4-~~,leek and 3 -month tin~epoints ~Tho have an 
antibody titer greater tha~~ i :40 whic~'i is considered a protective Level. There were no 
signif cant differences between the two groups. 
Vaccine and time point Exercise group Control group 
Type H1N1, 4 week $6% 43% 
Type H1N1, 3 month 83% 50% 
Type H3N2, 4 week 93 % 69% 
Type H3N2, 3 month 86% 69% 
Type B, 4 week 31 % 31 
Type B, 3 month 14% 3 3 
Table 3. ~~eans and standard error of~ nutrient intakes among the exercise and control 
Groups. 
Nutrient Exercise Group S.E. Control Group S,E. 
Vitamin E (milligrams) 102.7 353 183.2 64.1 
Vitamin C (milligrams) 334.4 76.2 47b.4 119 
Zinc (milligrams) 65.6 40.4 29.5 5.22 
Calories (kilocalories) 1817 219 1549 118 
Carbohydrate (grams) 210.5 19.8 186.7 15.4 
Fat (grams) 81.2 14.9 63.3 5.83 
Protein (grams) 68.7 9.12 61.0 5.47 
38 
DISCUSSION 
The findings from this study suggest that there is an association between physical 
activity and the immune response to influenza immunization in adults > 65 years of age. We 
observed that 10 months of moderate to vigorous aerobic exercise increased anti-influenza 
antibody titer. The antibody titer is the primary predictor for an immune response and has 
the best correlation with protection from influenza. During the four-week post time point, 
the antibody titer acts as a gold standard to demonstrate if the vaccine is effective. During 
this four-week post period, a peak increase in antibody titer should be seen if the vaccine is 
effective. An increase in antibody titers suggests improved vaccine efficacy. Our research 
demonstrated a peak increase in antibody titer during the four-week post for the exercise 
group within all three of the influenza vaccines. This study is the first one that we are aware 
of to examine immune response to influenza vaccine following an exercise intervention in 
older adults. One other published study evaluated the association between physical fitness 
and anti-influenza antibody titer in young adults. However, no association between fitness 
and antibody titer was found. T'he other study that showed an association between physical 
activity and immune response identified a greater antibody titer to the influenza 
immunization (25). 
Vaccine efficacy is reduced among older adults because of a decreased immune 
response. This puts the elderly at ri sk for serious morbidity and greater mortality rates from 
influenza infection than the younger population. Bernstein and colleagues found that a 
younger population had a higher antibody titer than an elderly population after vaccination 
(33). Although the elderly population has an increase in antibody titer from their pre- 
vaccination levels, the titer may not be high enough to provide protection again influenza. 
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Exercise may be one way to improve the efficacy of the influenza vaccine in the elderly. In 
our study, the exercise group had a greater antibody titer change from pre-vaccination than 
the control group. 
In our study, older individuals aged > 65 years of age participated in exercise for at 
least 20 minutes per session, three or more times per week at an intensity estimated to be 
approximately 65 to 75% of heart rate reserve for 10 months had a higher influenza- specif c 
antibody titer response than the control group. Although antibody titer to influenza vaccine 
was not different between exercise and control before the intervention, after 10 months of 
aerobic exercise, exercise subjects had a significantly higher antibody titer to the Type 
AH 1 N 1 and Type A H3N2 components of the influenza vaccine. However, cytokine 
production, more specifically interleukin-2, interleukin-10, and interferon gamma, did not 
appear to be associated with physical activity for the time points that were measured in the 
study. Also, lymphocyte proliferation of peripheral blood mononuclear cells did not appear 
to be affected by physical activity for the time points that were measured in this study. 
However, cytokine production and lymphocyte proliferation are not as great of indicators for 
a change in immune variables as the antibody titer. The antibody titer is the gold standard to 
monitor if there is a change in immune variables. Thus, there was an increase in antibody 
titer within the exercise group, suggesting that exercise does have a positive effect on 
antibody titer. These findings are similar to the first study mentioned above that had also 
shown an association between physical activity and greater antibody titer (25). However, 
within the first study, they also demonstrated that the more physically active individuals had 
a greater amount of influenza-specific lymphocyte proliferation than sedentary individuals. 
Previous studies have supported this theory of enhanced response in well-conditioned older 
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individuals compared to less active older individuals, although none of these studies have 
examined antigen-specifc immune response (23). Other controlled trials have reported that 
exercise has little or no effect on immune function. However, these studies were conducted 
over shorter periods of time (12 weeks-6 months) and perhaps a longer period of exercise is 
necessary to observe enhanced immune function. Research, in general, suggests that people 
who trained for many years seemed to show an increase in immune response (21). 
Looking at our findings, it would seem appropriate to conclude that the immune 
response to an influenza vaccine may be enhanced in older adults through exercise. 
Evidence shows that antibody titer in serum determined by hemagglutination inhibition, 
provides a great predictor of an individuals resistance to infection (34). A higher antibody 
titer provides greater protection from infection (35). In our study, the exercise subjects had a 
higher antibody titer suggesting a greater degree of protection from influenza. The incidence 
of infection was not signif cantly different between the exercise and control groups in our 
study. One control subject and no exercise subjects got influenza. A much larger sample 
size is necessary to detect differences in illness given that only a small number of individuals 
experience infection after receiving immunization. Antibody titer was higher in exercise 
group. 
Cell-mediated responses to the influenza virus are essential for viral clearance. Also, 
cell-mediated responses to influenza virus may provide cross-reactivity from strains of 
influenza that may not have been included in the annual influenza vaccine (15). In terms of 
cell-mediated responses to the influenza vaccination, we did not observe increased 
lymphocyte proliferation among the exercise group. There was also not an association 
between exercise and cytokine production. Considering that IL-2 promotes cell proliferation, 
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it is not surprising that we did not observe an increase in IL-2 given that we had not seen an 
increase in cell proliferation. Another cytokine, interferon gamma, is also important in cell-
mediated responses to viral infection. We did not observe an effect of exercise on influenza-
induced interferon gamma production. Others reported in older adults that cytokine 
production varies by individual influenza strain (36). In general, cell-mediated responses did 
not appear to be altered by exercise. However, there was a lot of variability in cytokine 
production and lymphocyte proliferation and perhaps a larger sample is needed to detect 
meaningful changes in cell-mediated immune responses. 
It was surprising that there was not an increase in IL-10 production among the 
exercise group. IL-10 is a Th2 cytokine that promotes antibody production. We observed an 
increase in antibody production among the exercise group, but not an increase in IL-10 
production compared to the control group. It is possible that IL-10 was different at other 
time-points. It is also possible that the cells producing IL-10 in the peripheral blood do not 
reflect IL-10 production in other immune tissues (spleen, lymph nodes). Perhaps if we had 
been able to measure IL-10 in other tissues, we may have seen a difference between exercise 
and control. 
The role of exercise in modulating antibody response to influenza immunization has 
been studied in college-aged individuals. However, no erect of exercise was found within 
this group (37). Perhaps, the immunomodulatory effects of exercise may be 
greater among the aged population compared to the younger populations (3 8). It could also 
be that different research techniques among young and old yield different results. 
We observed a higher IL-2 production within individuals who consumed less 
carbohydrate. Also, we observed a trend toward increased IL-2 production within . 
~~ 
Indlvldital~ wino consun~le greater vltan~lln E and vltanzln L Intakes. Given th e small nun-Iher 
of subjects, it is premature to make any diet<~.r~' supplement reconlrnendations, rather, it is 
important to consider nutrient intake as a factor when analyzing immune function in the 
elderly population, Cspecia.liy considering that n~iainutrition open exists iri ti'~is population. 
The primary mechanisms responsible for the exercise-induced enhancement of 
in~.n~~.ne unction are unknowr~. ~Teuroendocrine changes that occur during exercise niay 
mediate the alteration of the immune response (Tahie + j. The possi ale neuroendocrine 
changes due to exercise include %ilarlges iri a vas lety of neurohorn~ones, such as 
glucacorticoids, catecholamines, ~i-endorphins, acid giow-th horri~or~es. Aii of these 
near o~iormones have beers sho~v-n to alter the immune response (~ ~}. it has been tl-iought that 
during exercise glucocorticoids and catecholar~~ines are th e primary stressor ho~i~lones that 
~l.ffeCt t~iC Irllilluile System ~~0). Perhaps the regi.tiar release of catecllolan -Ilnes and/'or 
glucocorticoids improves immune responsiveness. A secondary- mechanism for altered 
imn~Iur~e response due to exercise may include psychosocial factors. Immune functioning is 
compromised with high levels of psychosocial stress and depression. I-Iowever, exercise relay 
attenuate psychosocial stress aril reduce depression, perhaps resulting in improved imn-~une 
unction. 
Table 4. Neurotransr~iitters and horn~iones vv-ith in-Imunomodulatory propertiesa. 
Factor Exercise result Action Ef, feet 
Glucocorticoids Increases S/E Antibody production, NK activity, cytokine production 
Catecholamines Increases S/E Lymphocyte proliferation to mitogen, cytokine production 
~3-endorphin Increases E/S Antibody synthesis, macrophage activation, T-cell activation 
Prolactin Increases E Macrophage activation, IL-2 production 
Growth hormone Increases E Antibody synthesis, macrophage activation, IL-2 modulation 
Vasopressin Increases E T-cell proliferation 
ACTH Increases E/S _ Cytokine production, NK activity, antibody synthesis 
3These represent general properties. In many cases, the action depends on the concentration, target 
cell a~~d i~ruttut~e futictioi~ studied. S: supp~res5iotl, E: etd~ai~c;enlent 
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CONCLUSION 
In summary, numerous changes occur in immune responsiveness among the elderly 
population. Influenza is a significant cause of mortality among this population group. 
Vaccine efficacy is reduced among the elderly population. It is significant to identify 
specific lifestyle habits that may enhance vaccine efficacy. The f ndings from this study 
suggest that regular, vigorous exercise for 25-30 minutes > 3 times per week for at least 10 
months may enhance immune response to influenza immunization by increasing antibody 
titer in older adults. The antibody titer is the primary predictor for an immune response. 
Further research to clarify the mechanisms responsible for enhanced immune function are 
necessary. It would be relevant to investigate the effects of a long-term exercise program on 
older adults, in terms of the immune response to influenza vaccination; and to examine 
exercise-associated alterations in psychological state as potential mediators of the exercise-
induced modulation of immunity. Perhaps the immunomodulatory effects of exercise are 
mediated by the binding of catecholamines released during exercise to lymphocyte beta- 
adrenergic receptors. A study that incorporates investigating the immune, psychological, and 
physiological responses will provide a basis for further study into the mechanisms mediating 
these relationships. 
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